- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04081870
IS Three d Power Doppler of the Endometrial and Subendometrial Regions Effective in Predicting Endometrial Implantation?
September 9, 2019 updated by: khalid mohammed salama, Benha University
IS Three d Power Doppler of the Endometrial and Subendometrial Regions Effective?
Three D power Doppler US was done for every woman at the day after HCG administration.
Ovum pick up was done after 35 hours following HCG administration.
The luteal phase was supported by progesterone 300 mg per day (progest, micronized progesterone 100mg, Technopharma, Egypt, for pharco pharmaceuticals, Amriya- Alexandria).
Five days following ovum pick up, the embryos were transferred at the blastocyst stage.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All women underwent long agonist protocol for controlled ovarian hyperstimulation described by Chang et al. (14) The GnRH agonist was started in the previous mid-luteal phase (decapeptylR R 0.1mg, Triptorelin-Acetate, Ferring GmbH, Wittland 11, D-24109, and Kiel, Germany).
After the confirmation of pituitary down regulation (serum LH less than 5 m IU/ml and serum E2 less than 50 pg /ml), the HMG ampoules were started by 225 IU/day (Gonapure 75 IU, IBSA Institute Biochimique SA, Switzerland).
During the follow up of overstimulation, the doses were adjusted according to the response of patient.
All women underwent serial TVS until at least three dominant follicles were reached in every woman.
When the dominant follicles reached 18-20 mm, HCG 10000 (Choriomon 5000 IU, IBSA Institute Biochimique SA, Switzerland) was administered.
Three D power Doppler US was done for every woman at the day after HCG administration.
Ovum pick up was done after 35 hours following HCG administration.
The luteal phase was supported by progesterone 300 mg per day (progest, micronized progesterone 100mg, Technopharma, Egypt, for pharco pharmaceuticals, Amriya- Alexandria).
Five days following ovum pick up, the embryos were transferred at the blastocyst stage.
Twelve days later to embryo transfer, serum pregnancy test was done and if positive (chemical pregnancy), the clinical pregnancy was confirmed by TVS for detection of gestational sacs and embryo cardiac activity.
The ongoing pregnancy was detected by abdominal ultrasound at 12 weeks.
Study Type
Observational
Enrollment (Actual)
120
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Probability Sample
Study Population
infertile women in need for ICSI due to male factor
Description
Inclusion Criteria:
a
- age; 22-35 years,
- BMI; less than 35 kg/m2,
- Husband with oligo- or oligoasthenospermia.
Exclusion Criteria:
- \1-gross uterine and tubal pathology,
- 2-Development of OHSS,
- 3-poor responders,
- 4-failure of oocyte fertilization or failure of the embryos to reach the blastocyst stage and
- 5-Refusal to participate in the study at any step of the ICSI cycle.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
ICSI cases
All women underwent long agonist protocol for controlled ovarian hyperstimulation The GnRH agonist was started in the previous mid-luteal phase .
After the confirmation of pituitary down regulation , the HMG ampoules were started by 225 IU/day .
During the follow up of overstimulation, the doses were adjusted according to the response of patient.
All women underwent serial TVS until at least three dominant follicles were reached in every woman.
When the dominant follicles reached 18-20 mm, HCG 10000 was administered.
Three D power Doppler US was done for every woman at the day after HCG administration.
Ovum pick up was done after 35 hours following HCG administration.
The luteal phase was supported by progesterone 300 mg per day .
Five days following ovum pick up, the embryos were transferred at the blastocyst stage.
|
Three D power Doppler US was done for every woman at the day after HCG administration.
Ovum pick up was done after 35 hours following HCG administration.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
chemical pregnancy
Time Frame: 14 day
|
positive pregnancy test
|
14 day
|
the clinical pregnancy
Time Frame: 28 day
|
was confirmed by TVS for detection of gestational sacs and embryo cardiac activity.
|
28 day
|
The ongoing pregnancy
Time Frame: 3 months
|
was detected by abdominal ultrasound at 12 weeks.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 1, 2014
Primary Completion (ACTUAL)
April 1, 2019
Study Completion (ACTUAL)
May 1, 2019
Study Registration Dates
First Submitted
September 5, 2019
First Submitted That Met QC Criteria
September 5, 2019
First Posted (ACTUAL)
September 9, 2019
Study Record Updates
Last Update Posted (ACTUAL)
September 11, 2019
Last Update Submitted That Met QC Criteria
September 9, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- khalid 6
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on 3D power doppler US
-
rasha medhat abdul-hadyUnknownPlacenta AccretaEgypt
-
Ain Shams Maternity HospitalCompleted
-
University Hospitals of Derby and Burton NHS Foundation...Not yet recruitingRecurrent Miscarriage
-
Cairo UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisPfizerUnknown
-
Catharina Ziekenhuis EindhovenEindhoven University of TechnologyUnknownUltrasound Therapy; Complications | Femoral Artery InjuryNetherlands
-
New York Presbyterian HospitalBayerCompletedInherited Bleeding DisordersUnited States
-
British Columbia Children's HospitalUniversity of British ColumbiaUnknownDevelopmental Dysplasia of the HipCanada
-
Peking University Third HospitalRecruiting
-
University Hospital, MontpellierCentral Hospital, Nancy, France; Centre Hospitalier de la côte Basque; University... and other collaboratorsCompletedObsessional ErotomaniaFrance